Cargando…

Hematomyelia associated with coronavirus disease 2019: A rare case report

Coronavirus disease 2019 (COVID-19) can damage the central nervous system. Although there have been reports of cerebral hemorrhage and infarction caused by COVID-19, hematomyelia due to COVID-19 has never been reported. PATIENT CONCERNS: A 40-year-old male was admitted to the hospital with positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lin-Ming, Zhang, Huan-Bo, Fan, Fu-Rong, Liu, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328563/
https://www.ncbi.nlm.nih.gov/pubmed/37417636
http://dx.doi.org/10.1097/MD.0000000000034197
_version_ 1785069823930138624
author Zhang, Lin-Ming
Zhang, Huan-Bo
Fan, Fu-Rong
Liu, Ming-Wei
author_facet Zhang, Lin-Ming
Zhang, Huan-Bo
Fan, Fu-Rong
Liu, Ming-Wei
author_sort Zhang, Lin-Ming
collection PubMed
description Coronavirus disease 2019 (COVID-19) can damage the central nervous system. Although there have been reports of cerebral hemorrhage and infarction caused by COVID-19, hematomyelia due to COVID-19 has never been reported. PATIENT CONCERNS: A 40-year-old male was admitted to the hospital with positive nucleic acid detection for COVID-19 after experiencing fever for 2 weeks, urinary retention, fecal retention, and pain in both lower extremities for a week. DIAGNOSES: The patient diagnosis was established using thoracic and lumbar magnetic resonance imaging (MRI). Contrast-enhanced thoracic and lumbar MRI revealed subdural (dorsal predominant) short T1 and slightly long T2 bands in the T12-S2 infundibular canal in the scan field, and the subdural hematoma was yet to be distinguished from other diseases. Spinal cord edema was observed in the left vertebral plate and facet joint of the T11 vertebral body, indicative of inflammation. The cerebrospinal fluid (CSF) was positive for COVID-19 nucleic acid. INTERVENTIONS: Antiinfection, immunomodulation, correction of acid-base balance and electrolyte disorders, improvement of circulation, nerve nutrition, and other symptomatic supportive treatments were administered to the patient. OUTCOMES: The patient symptoms significantly improved after 4 weeks of anti-infection and immunomodulatory therapy. Repeat thoracolumbar MRI revealed absorption of the spinal cord hematoma, and the patient was discharged from the hospital. To date, COVID-19-related hematomyelia has not been reported and anti-infective and immunomodulatory therapies may be effective. LESSONS: COVID-19 not only easily leads to brain injury but can also cause spinal cord injury and even spinal cord hemorrhage. When patients with COVID-19 experience symptoms and signs of spinal cord injury, spinal cord injury and bleeding caused by COVID-19 should be considered, and MRI and lumbar puncture should be performed as soon as possible to make a clear diagnosis.
format Online
Article
Text
id pubmed-10328563
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103285632023-07-08 Hematomyelia associated with coronavirus disease 2019: A rare case report Zhang, Lin-Ming Zhang, Huan-Bo Fan, Fu-Rong Liu, Ming-Wei Medicine (Baltimore) 5300 Coronavirus disease 2019 (COVID-19) can damage the central nervous system. Although there have been reports of cerebral hemorrhage and infarction caused by COVID-19, hematomyelia due to COVID-19 has never been reported. PATIENT CONCERNS: A 40-year-old male was admitted to the hospital with positive nucleic acid detection for COVID-19 after experiencing fever for 2 weeks, urinary retention, fecal retention, and pain in both lower extremities for a week. DIAGNOSES: The patient diagnosis was established using thoracic and lumbar magnetic resonance imaging (MRI). Contrast-enhanced thoracic and lumbar MRI revealed subdural (dorsal predominant) short T1 and slightly long T2 bands in the T12-S2 infundibular canal in the scan field, and the subdural hematoma was yet to be distinguished from other diseases. Spinal cord edema was observed in the left vertebral plate and facet joint of the T11 vertebral body, indicative of inflammation. The cerebrospinal fluid (CSF) was positive for COVID-19 nucleic acid. INTERVENTIONS: Antiinfection, immunomodulation, correction of acid-base balance and electrolyte disorders, improvement of circulation, nerve nutrition, and other symptomatic supportive treatments were administered to the patient. OUTCOMES: The patient symptoms significantly improved after 4 weeks of anti-infection and immunomodulatory therapy. Repeat thoracolumbar MRI revealed absorption of the spinal cord hematoma, and the patient was discharged from the hospital. To date, COVID-19-related hematomyelia has not been reported and anti-infective and immunomodulatory therapies may be effective. LESSONS: COVID-19 not only easily leads to brain injury but can also cause spinal cord injury and even spinal cord hemorrhage. When patients with COVID-19 experience symptoms and signs of spinal cord injury, spinal cord injury and bleeding caused by COVID-19 should be considered, and MRI and lumbar puncture should be performed as soon as possible to make a clear diagnosis. Lippincott Williams & Wilkins 2023-07-07 /pmc/articles/PMC10328563/ /pubmed/37417636 http://dx.doi.org/10.1097/MD.0000000000034197 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle 5300
Zhang, Lin-Ming
Zhang, Huan-Bo
Fan, Fu-Rong
Liu, Ming-Wei
Hematomyelia associated with coronavirus disease 2019: A rare case report
title Hematomyelia associated with coronavirus disease 2019: A rare case report
title_full Hematomyelia associated with coronavirus disease 2019: A rare case report
title_fullStr Hematomyelia associated with coronavirus disease 2019: A rare case report
title_full_unstemmed Hematomyelia associated with coronavirus disease 2019: A rare case report
title_short Hematomyelia associated with coronavirus disease 2019: A rare case report
title_sort hematomyelia associated with coronavirus disease 2019: a rare case report
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328563/
https://www.ncbi.nlm.nih.gov/pubmed/37417636
http://dx.doi.org/10.1097/MD.0000000000034197
work_keys_str_mv AT zhanglinming hematomyeliaassociatedwithcoronavirusdisease2019ararecasereport
AT zhanghuanbo hematomyeliaassociatedwithcoronavirusdisease2019ararecasereport
AT fanfurong hematomyeliaassociatedwithcoronavirusdisease2019ararecasereport
AT liumingwei hematomyeliaassociatedwithcoronavirusdisease2019ararecasereport